Study on COVID-19 Vaccine Effectiveness Published After Initial Delay
A recent study examining the effectiveness of COVID-19 vaccines has been released after facing challenges in publication. The study, published by JAMA Network Open, reveals that the vaccine is about 55% effective in preventing COVID-19-related hospitalizations. Additionally, it shows a 50% reduction in emergency department and urgent care visits for COVID-19 symptoms.
The findings are consistent with previous research indicating that vaccines help against COVID-19. However, public interest in the study rose due to its initial blockage by political appointees in the Trump administration. They argued the study’s design could lead to inaccurate conclusions.
Despite those concerns, many experts consider the design sound. Natalie Dean from Emory University emphasized the importance of continuously publishing vaccine effectiveness estimates, particularly as immunity changes and virus strains evolve.
The study was initially set for publication in the Morbidity and Mortality Weekly Report by the CDC. It received clearance but was halted by acting director Jay Bhattacharya, according to CDC’s chief science officer, Althea Grant-Lenzy. The delay required addressing specific concerns.
The study employed a ‘test-negative design’ approach, examining hospital and emergency room patients with respiratory symptoms. It assessed vaccination status and COVID-19 test results to determine effectiveness. This design has been validated in journals such as Pediatrics and the New England Journal of Medicine.
Bhattacharya criticized the study for potential bias from assumptions about prior infections. Advocates argue the methodology effectively accounts for healthcare-seeking behavior differences and that most Americans have been exposed to the virus, minimizing bias.
The CDC recently hosted a forum to debate the methodology, featuring experts including Martin Kulldorff, who criticized the broader inclusion criteria. He questioned why longer studies weren’t utilized, given the pandemic’s urgency.
The Associated Press Health and Science Department, responsible for the article content, is supported by the Howard Hughes Medical Institute’s Science Education Department and the Robert Wood Johnson Foundation.